Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19860

Title:	Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE study
Authors:	Ziemssen, T. Hobart, J. FEYS, Peter Linnebank, M. Goodman, A. McNeill, M. Zhong, J. Mehta, L.
Issue Date:	2015
Publisher:	WILEY-BLACKWELL
Source:	EUROPEAN JOURNAL OF NEUROLOGY, 22 (S1), p. 621-621
Notes:	[Ziemssen, T.] Univ Clin Dresden, Dresden, Germany. [Hobart, J.] Univ Plymouth, Peninsula Sch Med, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Hobart, J.] Univ Plymouth, Peninsula Sch Dent, Plymouth Hosp NHS Trust, Plymouth PL4 8AA, Devon, England. [Feys, P.] Univ Hasselt, Diepenbeek, Belgium. [Linnebank, M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland. [Goodman, A.] Univ Rochester, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA. [McNeill, M.] Biogen Idec Inc, Maidenhead, Berks, England. [Zhong, J.; Mehta, L.] Biogen Idec Inc, Cambridge, MA USA.
Document URI:	http://hdl.handle.net/1942/19860
ISSN:	1351-5101
e-ISSN:	1468-1331
ISI #:	000364239000254
Rights:	© 2015 European Journal of Neurology
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

File	Description	Size	Format
selection (34).pdf Restricted Access		194.07 kB	Adobe PDF	View/Open Request a copy

Check